Old MRP ₹270
MRP ₹253.13
₹202.5
₹16.88/Units
Use current location
Login to view saved addresses
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Below 30o C
Trivolib 1 Tablet is used to manage uncontrolled type 2 diabetes mellitus. This anti-diabetic combination uses glimepiride, metformin, and voglibose. The triple action works synergistically by increasing insulin sensitivity, reducing hepatic glucose production, and critically, slowing down carbohydrate absorption. This provides crucial blood sugar control in adults whose condition is poorly managed by dual therapy.
Trivolib 1 Tablet is used for the management of type 2 diabetes mellitus in adults, assisting in controlling blood sugar levels and supporting diabetic adults who have not achieved adequate glycemic control with the individual components of this combination.
Swallow the tablet whole with a glass of water.
Do not chew, crush, or split the tablet.
Never take more than the recommended dose without consulting your doctor.
It's crucial not to stop taking this medicine without discussing it with your doctor first.
Trivolib 1 Tablet is taken orally.
Trivolib 1 Tablet may cause hypoglycaemia (low blood sugar), nausea, diarrhoea, abdominal pain, flatulence, and headache. Speak to your healthcare provider if these side effects persist.
Most side effects are temporary and generally harmless, which resolve on discontinuing the use of Trivolib 1 Tablet. However, if you experience any serious side effects or worsening of any of the symptoms, please consult your doctor.
Here are some general guidelines for managing common side effects:
Hypoglycaemia: Try taking Trivolib 1 Tablet with a meal to help reduce this effect.
Diarrhoea: Consume plenty of water and healthy fluids to avoid dehydration.
Trivolib 1 Tablet contains three active ingredients working together to control blood sugar levels:
Glimepiride (1 mg): This is a sulfonylurea that works by stimulating the pancreas to release more insulin. More insulin helps to reduce blood sugar levels.
Metformin (500 mg): Known as a biguanide, metformin reduces the production of glucose in the liver. It also decreases the intestinal absorption of glucose and improves the body's sensitivity to insulin.
Voglibose (0.2 mg): Voglibose is an alpha-glucosidase inhibitor. It slows down the breakdown of complex carbohydrates in the intestine, which helps to reduce spikes in blood sugar levels after meals.
Caution is advised while taking Trivolib 1 Tablet if you are pregnant. The medicine should be used only if the potential benefit justifies the potential risk to the fetus. It is best to consult your doctor before taking this medicine.
Metformin, an ingredient in Trivolib 1 Tablet, is excreted in human milk. Caution should be exercised when this medicine is taken by a nursing woman. Always discuss this with your doctor.
Drinking alcohol while on Trivolib 1 Tablet could increase the risk of lactic acidosis and hypoglycaemia. It's advisable to limit your alcohol intake or avoid it altogether while using this medicine.
Trivolib 1 Tablet should be avoided in patients with liver impairment due to the increased risk of lactic acidosis. If you have liver problems, consult your doctor before starting this medication.
People with severe renal impairment should not take Trivolib 1 Tablet. If you have a history of kidney problems, discuss them with your doctor before starting this medication as it may require dose adjustments.
No known effect on driving or operating machinery has been reported with Trivolib 1 Tablet. However, caution is advised as low blood sugar (hypoglycaemia) can occur, which may affect your ability to drive or use machines.
This medication is contraindicated for individuals who are allergic to glimepiride, metformin, voglibose or any other component of Trivolib 1 Tablet.
The safety and effectiveness of Trivolib 1 Tablet in children have not been established yet. It's always advisable to consult your doctor before giving any medication to a child.
Elderly patients, especially those with impaired kidney function, may require dose adjustments when taking Trivolib 1 Tablet. Discuss any liver or kidney-related concerns with your doctor before starting this medication.
Trivolib 1 Tablet interacts with the following medicines:
Insulin and other anti-diabetic agents: Medicines like insulin glargine and glipizide may interact with Trivolib 1 Tablet, causing a higher risk of low blood sugar levels (hypoglycaemia).
Thiazide diuretics: Medications such as hydrochlorothiazide or indapamide can interact with Trivolib 1 Tablet, potentially leading to high blood sugar levels (hyperglycaemia).
Corticosteroids and sympathomimetic agents: Medicines like prednisolone, epinephrine, and pseudoephedrine can reduce the blood sugar control effect of this tablet.
Iodinated contrast agents: Agents such as iodixanol or iohexol might increase the risk of acute kidney failure and lactic acidosis when taken with this medicine.
No food interacts with Trivolib 1 Tablet.
Trivolib 1 Tablet interacts with the following diseases:
Kidney Disease: If you have severe kidney impairment, you should avoid taking this medicine due to a higher risk of lactic acidosis.
Liver Disease: People with liver problems should avoid this medication as it could worsen their condition.
Metabolic Acidosis: This medication is not advised for people suffering from metabolic acidosis as it could exacerbate their condition.
The daily dosage of Trivolib 1 Tablet should be as advised by your doctor. The prescribed dosage can vary based on individual factors such as the severity of your condition and response to the medicine. Ensure you follow the prescribed dosage and don't exceed it without consulting your doctor.
If you accidentally take more than the prescribed dose of Trivolib 1 Tablet, you may experience common symptoms such as nausea, diarrhoea, and abdominal pain. In case these symptoms persist or worsen, inform your doctor.
If you forget to take your regular dose of Trivolib 1 Tablet, take it as soon as you remember. However, if it's nearly time for your next dose, skip the missed one and continue with your regular dosage schedule. Never change your dosage without consulting your doctor.
Keep Trivolib 1 Tablet at room temperature, specifically between 20°C and 25°C.
Protect the medicine from light and moisture.
Ensure it is out of reach of children.
Use your Trivolib 1 Tablet before the expiry date printed on the package.
Regularly monitor your blood sugar levels. This will help you understand how different foods affect your body and manage your diabetes better.
Incorporate a balanced diet and regular exercise into your lifestyle. This will aid in controlling your blood sugar levels, alongside taking Trivolib 1 Tablet.
| Available Dosage Types | Tablet |
| Habit Forming | No |
| Ailment | Type 2 Diabetes Mellitus |
| Drug Category | Sulfonylurea, Biguanide, Alpha-Glucosidase Inhibitor |
| Therapeutic Category | Antidiabetic |
Trivolib 1 Tablet is an oral medicine used to manage type 2 diabetes in adults, alongside a balanced diet and exercise regimen.
It combines three active ingredients that work together to lower blood sugar levels by increasing insulin production, reducing glucose absorption, and slowing carbohydrate breakdown.
You must take the medicine as directed by your doctor.
No, it's not suitable for people with type 1 diabetes, severe kidney problems, certain allergies, or metabolic acidosis. Always consult your doctor first.
Common side effects can include low blood sugar, nausea, vomiting, abdominal pain, flatulence, headache and diarrhoea.
Some medications may interact with Trivolib 1 Tablet leading to increased risks. Always inform your doctor about all medications you are taking.
Store at room temperature between 20°C and 25°C, away from light and moisture. Always keep out of reach of children.
Check out Editorial Policy
Dailymed—Metformin er 500 mg tablet metformin er 750 mg tablet. (n.d.). Retrieved 13 October 2024, from https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b857eccf-b9ff-45ba-8241-f47f5caada2a
FDA. (n.d.). FDA Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function. Retrieved April 1, 2024, from https://www.fda.gov/downloads/drugs/drugsafety/ucm280360.pdf
NHS UK. (n.d.). Glimepiride. Retrieved April 1, 2024, from https://www.nhs.uk/medicines/glimepiride/how-and-when-to-take-glimepiride/
Voglibose. (n.d.). Retrieved 13 October 2024, from
Metformin. (n.d.). Retrieved 13 October 2024, from
Glimepiride. (n.d.). Retrieved 13 October 2024, from
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
61% CHEAPER
4383 users bought this instead
...View more
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.14.0
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
Composition
